E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 2.156 EUR -2% Market Closed
Market Cap: 206.1m EUR

Euroapi SAS
Common Shares Outstanding

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Euroapi SAS
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
E
Euroapi SAS
PAR:EAPI
Common Shares Outstanding
€95m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Sanofi SA
PAR:SAN
Common Shares Outstanding
€1.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ipsen SA
PAR:IPN
Common Shares Outstanding
€83m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Vetoquinol SA
PAR:VETO
Common Shares Outstanding
€11.8m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Virbac SA
PAR:VIRP
Common Shares Outstanding
€8.4m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Medincell SA
PAR:MEDCL
Common Shares Outstanding
€33m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
N/A
No Stocks Found

Euroapi SAS
Glance View

Market Cap
204.8m EUR
Industry
Pharmaceuticals

EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.

EAPI Intrinsic Value
6.941 EUR
Undervaluation 69%
Intrinsic Value
Price
E

See Also

What is Euroapi SAS's Common Shares Outstanding?
Common Shares Outstanding
95m EUR

Based on the financial report for Dec 31, 2024, Euroapi SAS's Common Shares Outstanding amounts to 95m EUR.

What is Euroapi SAS's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
1%

Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for Euroapi SAS have been 2% over the past three years , 1% over the past five years .

Back to Top